Taking into account the recent acquisition of Nevro, the net sales for the fiscal year 2025 are projected to be between $2.80 billion and $2.90 billion, with net EPS estimated to be in the range of $3 ...

Taking into account the recent acquisition of Nevro, the net sales for the fiscal year 2025 are projected to be between $2.80 billion and $2.90 billion, with net EPS estimated to be in the range ...

On December 1, 2024, Nevro Corp. became aware of a security incident on its network. Upon detection, Nevro launched an investigation with the assistance of third-party cyber security experts to ...

On December 1, 2024, Nevro Corp. became aware of a security incident on its network. Upon detection, Nevro launched an investigation with the assistance of third-party cyber security experts to ...

StockNews.com started coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the treatment ...

The increasing global incidence of chronic diseases—such as arthritis, epilepsy, Parkinson’s disease, depression, and cardiovascular disorders—has accelerated the demand for alternative treatment ...

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access.